{
  "metadata": {
    "version": "1.1",
    "last_updated": "2025-09-15",
    "focus_population": "Professional men aged 25-55 with ADHD",
    "quality_criteria": {
      "systematic_reviews": "PRISMA guidelines compliance",
      "meta_analyses": "GRADE evidence assessment",
      "rcts": "Cochrane risk of bias tool",
      "minimum_sample_size": 50,
      "follow_up_duration": "minimum 12 weeks"
    }
  },
  "research_entries": [
    {
      "id": "lancet_2025_ostinelli_network_meta",
      "title": "Comparative efficacy and acceptability of pharmacological, psychological, and neurostimulatory interventions for ADHD in adults: a systematic review and component network meta-analysis",
      "authors": [
        "Edoardo G Ostinelli",
        "Marcel Schulze",
        "Caroline Zangani",
        "Luis C Farhat",
        "Anneka Tomlinson",
        "Cinzia Del Giovane"
      ],
      "journal": "The Lancet Psychiatry",
      "publication_date": "2025-01-01",
      "doi": "10.1016/S2215-0366(24)00360-2",
      "study_type": "systematic_review",
      "evidence_level": "1a",
      "sample_size": 14887,
      "target_population": {
        "age_range": "\u226518 years",
        "gender": "51.3% male, 45.6% female",
        "occupation": "Mixed adult population",
        "adhd_subtype": "All subtypes"
      },
      "methodology": {
        "design": "Systematic review and component network meta-analysis",
        "duration": "\u22651 week for medications, \u22654 sessions for psychological therapies",
        "primary_outcomes": [
          "ADHD core symptom severity",
          "All-cause discontinuation"
        ],
        "secondary_outcomes": [
          "Quality of life measures",
          "Functional outcomes"
        ]
      },
      "key_findings": {
        "primary_results": "Stimulants and atomoxetine were the only interventions with evidence of beneficial effects on both self-reported and clinician-reported ADHD symptoms. Non-pharmacological interventions showed inconsistent effects across different raters.",
        "effect_sizes": {
          "stimulants_self_reported": -0.39,
          "stimulants_clinician_reported": -0.61,
          "atomoxetine_self_reported": -0.38,
          "atomoxetine_clinician_reported": -0.51,
          "cbt_clinician_reported": -0.76
        },
        "clinical_significance": "Stimulants and atomoxetine represent first-line pharmacological treatments with consistent efficacy across rating scales",
        "limitations": [
          "Short-term focus",
          "Limited quality of life data",
          "Inconsistent non-pharmacological effects"
        ]
      },
      "workplace_relevance": {
        "productivity_impact": "Short-term efficacy data applicable to working adults requiring rapid symptom improvement",
        "accommodation_needs": [
          "Medication adherence support",
          "Flexible scheduling for therapy"
        ],
        "career_implications": "Acceptability concerns with atomoxetine may affect long-term treatment adherence"
      },
      "quality_assessment": {
        "risk_of_bias": "low",
        "grade_rating": "moderate",
        "reviewer_notes": "Comprehensive methodology with component network meta-analysis approach"
      },
      "clinical_applications": {
        "diagnostic_utility": "Supports evidence-based treatment selection for adult ADHD",
        "treatment_recommendations": [
          "Stimulants as first-line",
          "Atomoxetine as alternative",
          "CBT as adjunctive therapy"
        ],
        "monitoring_parameters": [
          "Symptom severity scales",
          "Discontinuation rates",
          "Functional outcomes"
        ]
      },
      "tags": [
        "systematic_review",
        "network_meta_analysis",
        "pharmacological",
        "non_pharmacological",
        "adult_adhd",
        "treatment_efficacy"
      ],
      "added_date": "2025-09-15",
      "last_reviewed": "2025-09-15"
    },
    {
      "id": "frontiers_2025_yang_nonpharmaco_network",
      "title": "Short-term and long-term effect of non-pharmacotherapy for adults with ADHD: a systematic review and network meta-analysis",
      "authors": [
        "Xinyue Yang",
        "Lin Zhang",
        "Jing Yu",
        "Meng Wang"
      ],
      "journal": "Frontiers in Psychiatry",
      "publication_date": "2025-01-31",
      "doi": "10.3389/fpsyt.2025.1516878",
      "study_type": "systematic_review",
      "evidence_level": "1a",
      "sample_size": 2289,
      "target_population": {
        "age_range": "Adults",
        "gender": "Mixed",
        "occupation": "General adult population",
        "adhd_subtype": "All subtypes"
      },
      "methodology": {
        "design": "Systematic review and network meta-analysis",
        "duration": "Short-term and long-term follow-up",
        "primary_outcomes": [
          "Core ADHD symptoms",
          "Depression",
          "Anxiety"
        ],
        "secondary_outcomes": [
          "Functional outcomes",
          "Quality of life"
        ]
      },
      "key_findings": {
        "primary_results": "CBT showed exceptionally large effect sizes for both short-term and long-term improvement in core ADHD symptoms, depression, and anxiety. Mindfulness-based cognitive therapy recommended for patients without comorbidities.",
        "effect_sizes": {
          "cbt_adhd_short_term": -4.43,
          "cbt_adhd_long_term": -3.61,
          "cbt_depression_short_term": -4.16,
          "cbt_depression_long_term": -3.89,
          "cbt_anxiety_short_term": -2.12,
          "cbt_anxiety_long_term": -7.25
        },
        "clinical_significance": "CBT demonstrates very large and sustained effects on ADHD symptoms and comorbid emotional disorders",
        "limitations": [
          "High risk of bias in 48.6% of studies",
          "Very low to low confidence in most treatment effects"
        ]
      },
      "workplace_relevance": {
        "productivity_impact": "Long-term CBT effects particularly valuable for sustained workplace functioning",
        "accommodation_needs": [
          "Structured CBT program access",
          "Time for therapy sessions"
        ],
        "career_implications": "Emotional regulation improvements critical for professional advancement"
      },
      "quality_assessment": {
        "risk_of_bias": "moderate",
        "grade_rating": "low",
        "reviewer_notes": "Large effect sizes but quality concerns in underlying studies"
      },
      "clinical_applications": {
        "diagnostic_utility": "Supports CBT as primary non-pharmacological intervention",
        "treatment_recommendations": [
          "CBT for comprehensive symptom management",
          "Mindfulness-based therapy for uncomplicated cases"
        ],
        "monitoring_parameters": [
          "ADHD symptom scales",
          "Depression and anxiety measures",
          "Long-term functional outcomes"
        ]
      },
      "tags": [
        "systematic_review",
        "network_meta_analysis",
        "non_pharmacological",
        "cbt",
        "mindfulness",
        "long_term_outcomes"
      ],
      "added_date": "2025-09-15",
      "last_reviewed": "2025-09-15"
    },
    {
      "id": "jmir_2025_oscarsson_workplace_stress",
      "title": "Web-Based Stress Management for Working Adults With Attention-Deficit/Hyperactivity Disorder (ADHD): Single-Arm, Open Pilot Trial",
      "authors": [
        "Martin Oscarsson",
        "Sandra Hammarb\u00e4ck",
        "Karolina Blom Wiberg",
        "Alexander Rozental",
        "Ylva Ginsberg",
        "Per Carlbring",
        "Gerhard Andersson",
        "Fredrik J\u00f6nsson"
      ],
      "journal": "JMIR Formative Research",
      "publication_date": "2025-05-29",
      "doi": "10.2196/66388",
      "study_type": "rct",
      "evidence_level": "2b",
      "sample_size": 36,
      "target_population": {
        "age_range": "Working adults",
        "gender": "Mixed working adults",
        "occupation": "Professional working adults",
        "adhd_subtype": "All subtypes"
      },
      "methodology": {
        "design": "Single-arm open pilot trial",
        "duration": "12-week intervention with 12-week follow-up",
        "primary_outcomes": [
          "Quality of life (AAQoL)",
          "Perceived stress",
          "Exhaustion"
        ],
        "secondary_outcomes": [
          "ADHD symptoms",
          "Anxiety",
          "Depression"
        ]
      },
      "key_findings": {
        "primary_results": "Web-based CBT intervention produced large to very large effect sizes across all measured domains with high adherence and no dropouts. 36% of participants showed clinically significant improvement in quality of life.",
        "effect_sizes": {
          "quality_of_life": 0.84,
          "adhd_symptoms": 0.98,
          "perceived_stress": 0.83,
          "exhaustion": 1.12,
          "anxiety": 1.7,
          "depression": 1.25
        },
        "clinical_significance": "Demonstrates feasibility and effectiveness of workplace-focused ADHD interventions",
        "limitations": [
          "Single-arm design",
          "Small sample size",
          "Pilot study requiring replication"
        ]
      },
      "workplace_relevance": {
        "productivity_impact": "Very large effect on exhaustion and stress directly relevant to workplace performance",
        "accommodation_needs": [
          "Web-based platform access",
          "Flexible scheduling for modules"
        ],
        "career_implications": "Comprehensive improvement in professional functioning and stress management"
      },
      "quality_assessment": {
        "risk_of_bias": "moderate",
        "grade_rating": "moderate",
        "reviewer_notes": "Pilot study with promising results but limited by single-arm design"
      },
      "clinical_applications": {
        "diagnostic_utility": "Supports workplace-focused intervention approaches",
        "treatment_recommendations": [
          "Web-based CBT for working adults",
          "Stress management focus",
          "Executive function training"
        ],
        "monitoring_parameters": [
          "Quality of life measures",
          "Workplace stress indicators",
          "ADHD symptom severity"
        ]
      },
      "tags": [
        "pilot_study",
        "workplace_intervention",
        "web_based",
        "cbt",
        "stress_management",
        "working_adults",
        "professional_men"
      ],
      "added_date": "2025-09-15",
      "last_reviewed": "2025-09-15"
    },
    {
      "id": "mecp_2025_amiri_emotional_dysregulation",
      "title": "Pharmacological interventions for emotional dysregulation in ADHD: a meta-analysis stratified by sex and ADHD subtypes",
      "authors": [
        "Davoud Amiri",
        "Lamberto Briziarelli",
        "Enrico Tempesta",
        "Hadi Rahimi Danesh",
        "Amir Hossein Jalali Nadoushan",
        "Barry Karlsson"
      ],
      "journal": "Middle East Current Psychiatry",
      "publication_date": "2025-09-23",
      "doi": "10.1186/s43045-025-00570-6",
      "study_type": "meta_analysis",
      "evidence_level": "1a",
      "sample_size": 20,
      "target_population": {
        "age_range": "Adults",
        "gender": "Stratified by sex",
        "occupation": "Not specified",
        "adhd_subtype": "Stratified by subtype"
      },
      "methodology": {
        "design": "Meta-analysis of 20 peer-reviewed studies",
        "duration": "Not specified",
        "primary_outcomes": [
          "Emotional dysregulation (ED) outcomes"
        ],
        "secondary_outcomes": []
      },
      "key_findings": {
        "primary_results": "Pharmacological treatment significantly reduces emotional dysregulation in ADHD, with central stimulants demonstrating the strongest efficacy. Guanfacine and atomoxetine demonstrated moderate efficacy, especially in individuals with the inattentive subtype and in females.",
        "effect_sizes": {},
        "clinical_significance": "Clinicians should incorporate sex and ADHD subtype-specific stratifications to optimize personalized pharmacological strategies and improve patient outcomes.",
        "limitations": []
      },
      "workplace_relevance": {
        "productivity_impact": "Improved emotional regulation can lead to better workplace performance and interpersonal relationships.",
        "accommodation_needs": [],
        "career_implications": "Better management of emotional dysregulation can lead to improved career progression and job satisfaction."
      },
      "quality_assessment": {
        "risk_of_bias": "Not specified",
        "grade_rating": "Not specified",
        "reviewer_notes": "Meta-analysis of 20 studies, providing a good level of evidence."
      },
      "clinical_applications": {
        "diagnostic_utility": "Highlights the importance of assessing and treating emotional dysregulation in ADHD.",
        "treatment_recommendations": [
          "Central stimulants are most effective for emotional dysregulation.",
          "Guanfacine and atomoxetine are effective alternatives, especially for inattentive subtype and females."
        ],
        "monitoring_parameters": [
          "Emotional dysregulation scales"
        ]
      },
      "tags": [
        "meta_analysis",
        "pharmacological",
        "emotional_dysregulation",
        "adult_adhd",
        "sex_differences",
        "adhd_subtypes"
      ],
      "added_date": "2025-09-29",
      "last_reviewed": "2025-09-29"
    },
    {
      "id": "frontiers_2025_yang_nonpharmaco_network_2",
      "title": "Short-term and long-term effect of non-pharmacotherapy for adults with ADHD: a systematic review and network meta-analysis",
      "authors": [
        "Xinyue Yang",
        "Lin Zhang",
        "Jing Yu",
        "Meng Wang"
      ],
      "journal": "Frontiers in Psychiatry",
      "publication_date": "2025-01-31",
      "doi": "10.3389/fpsyt.2025.1516878",
      "study_type": "systematic_review",
      "evidence_level": "1a",
      "sample_size": 2289,
      "target_population": {
        "age_range": "Adults",
        "gender": "Mixed",
        "occupation": "General adult population",
        "adhd_subtype": "All subtypes"
      },
      "methodology": {
        "design": "Systematic review and network meta-analysis",
        "duration": "Short-term and long-term follow-up",
        "primary_outcomes": [
          "Core ADHD symptoms",
          "Depression",
          "Anxiety"
        ],
        "secondary_outcomes": [
          "Functional outcomes",
          "Quality of life"
        ]
      },
      "key_findings": {
        "primary_results": "CBT showed exceptionally large effect sizes for both short-term and long-term improvement in core ADHD symptoms, depression, and anxiety. Mindfulness-based cognitive therapy recommended for patients without comorbidities.",
        "effect_sizes": {
          "cbt_adhd_short_term": -4.43,
          "cbt_adhd_long_term": -3.61,
          "cbt_depression_short_term": -4.16,
          "cbt_depression_long_term": -3.89,
          "cbt_anxiety_short_term": -2.12,
          "cbt_anxiety_long_term": -7.25
        },
        "clinical_significance": "CBT demonstrates very large and sustained effects on ADHD symptoms and comorbid emotional disorders",
        "limitations": [
          "High risk of bias in 48.6% of studies",
          "Very low to low confidence in most treatment effects"
        ]
      },
      "workplace_relevance": {
        "productivity_impact": "Long-term CBT effects particularly valuable for sustained workplace functioning",
        "accommodation_needs": [
          "Structured CBT program access",
          "Time for therapy sessions"
        ],
        "career_implications": "Emotional regulation improvements critical for professional advancement"
      },
      "quality_assessment": {
        "risk_of_bias": "moderate",
        "grade_rating": "low",
        "reviewer_notes": "Large effect sizes but quality concerns in underlying studies"
      },
      "clinical_applications": {
        "diagnostic_utility": "Supports CBT as primary non-pharmacological intervention",
        "treatment_recommendations": [
          "CBT for comprehensive symptom management",
          "Mindfulness-based therapy for uncomplicated cases"
        ],
        "monitoring_parameters": [
          "ADHD symptom scales",
          "Depression and anxiety measures",
          "Long-term functional outcomes"
        ]
      },
      "tags": [
        "systematic_review",
        "network_meta_analysis",
        "non_pharmacological",
        "cbt",
        "mindfulness",
        "long_term_outcomes"
      ],
      "added_date": "2025-09-29",
      "last_reviewed": "2025-09-29"
    }
  ],
  "evidence_levels": {
    "1a": "Systematic review of RCTs",
    "1b": "Individual RCT with narrow confidence interval",
    "2a": "Systematic review of cohort studies",
    "2b": "Individual cohort study",
    "3a": "Systematic review of case-control studies",
    "3b": "Individual case-control study",
    "4": "Case series",
    "5": "Expert opinion"
  },
  "research_categories": {
    "diagnosis": "Diagnostic criteria, screening tools, assessment methods",
    "treatment": "Pharmacological and non-pharmacological interventions",
    "workplace": "Occupational functioning, accommodations, productivity",
    "comorbidities": "Co-occurring conditions and their management",
    "outcomes": "Long-term outcomes, quality of life measures",
    "biomarkers": "Neurobiological markers and genetic factors"
  },
  "schema": {
    "research_entry": {
      "id": "string - unique identifier",
      "title": "string - study title",
      "authors": "array - list of authors",
      "journal": "string - publication venue",
      "publication_date": "string - YYYY-MM-DD format",
      "doi": "string - digital object identifier",
      "study_type": "string - systematic_review|meta_analysis|rct|cohort|case_control",
      "evidence_level": "string - 1a|1b|2a|2b|3a|3b|4|5",
      "sample_size": "number - total participants",
      "target_population": {
        "age_range": "string - age demographics",
        "gender": "string - gender distribution",
        "occupation": "string - professional status",
        "adhd_subtype": "string - inattentive|hyperactive|combined"
      },
      "methodology": {
        "design": "string - study design details",
        "duration": "string - follow-up period",
        "primary_outcomes": "array - main outcome measures",
        "secondary_outcomes": "array - additional measures"
      },
      "key_findings": {
        "primary_results": "string - main findings",
        "effect_sizes": "object - statistical measures",
        "clinical_significance": "string - practical implications",
        "limitations": "array - study limitations"
      },
      "workplace_relevance": {
        "productivity_impact": "string - work performance effects",
        "accommodation_needs": "array - workplace modifications",
        "career_implications": "string - professional development"
      },
      "quality_assessment": {
        "risk_of_bias": "string - low|moderate|high",
        "grade_rating": "string - high|moderate|low|very_low",
        "reviewer_notes": "string - quality assessment notes"
      },
      "clinical_applications": {
        "diagnostic_utility": "string - assessment implications",
        "treatment_recommendations": "array - clinical guidance",
        "monitoring_parameters": "array - follow-up measures"
      },
      "tags": "array - searchable keywords",
      "added_date": "string - YYYY-MM-DD format",
      "last_reviewed": "string - YYYY-MM-DD format"
    }
  }
}